What one share of Amphastar Pharmaceuticals holds
We are a biopharmaceutical company focusing on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as active pharmaceutical ingredient, or API products.
Amphastar Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $15.73 |
|---|---|
| Profit | $1.69 |
| Capex (buildings and equipment) | $0.68 |
| Free cash flow | $3.30 |
| Cash and investments | $5.26 |
| Debt | $14.39 |
| Book value | $18.06 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2012 | $5.25 | $0.46 | $0.59 | −$0.64 | — | $6.05 |
| 2013 | $5.91 | $0.31 | $0.45 | $0.34 | — | $6.49 |
| 2014 | $5.02 | −$0.26 | $0.49 | $0.01 | — | $6.31 |
| 2015 | $5.59 | −$0.06 | $0.36 | −$0.12 | — | $6.54 |
| 2016 | $5.37 | $0.21 | $0.45 | $0.36 | — | $7.12 |
| 2017 | $4.97 | $0.08 | $0.73 | $0.09 | — | $7.16 |
| 2018 | $6.35 | −$0.12 | $1.01 | −$0.19 | — | $7.13 |
| 2019 | $6.46 | $0.98 | $0.83 | $0.00 | — | $8.19 |
| 2020 | $7.12 | $0.03 | $0.69 | $0.48 | — | $8.47 |
| 2021 | $8.79 | $1.25 | $0.55 | $1.42 | — | $9.34 |
| 2022 | $9.52 | $1.74 | $0.46 | $1.24 | — | $10.99 |
| 2023 | $12.16 | $2.60 | $0.72 | $2.74 | — | $13.30 |
| 2024 | $14.06 | $3.06 | $0.79 | $3.31 | — | $15.38 |
| 2025 | $14.93 | $2.03 | $0.72 | $2.51 | — | $17.28 |
Common questions about Amphastar Pharmaceuticals
How much does one share of Amphastar Pharmaceuticals earn?
Over the last 12 months, each share of Amphastar Pharmaceuticals earned $1.69 of profit on $15.73 of sales, keeping about 11¢ of every $1 (profit margin).
Does Amphastar Pharmaceuticals pay a dividend?
Amphastar Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Amphastar Pharmaceuticals’s book value per share?
Amphastar Pharmaceuticals’s book value is $18.06 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Amphastar Pharmaceuticals have?
Each share of Amphastar Pharmaceuticals has $5.26 of cash and investments and $14.39 of debt, as of June 30, 2026.
What is Amphastar Pharmaceuticals’s free cash flow per share?
$3.30 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
How has Amphastar Pharmaceuticals’s profit per share changed over time?
Profit per share went from $0.46 in 2012 to $2.03 in 2025, growing about 12.0% a year (adjusted for stock splits).
Has Amphastar Pharmaceuticals bought back shares?
Amphastar Pharmaceuticals’s share count rose about 24% from 2012 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.